© Springer International Publishing Switzerland 2015Omer Engin (ed.)Colon Polyps and the Prevention of Colorectal Cancer10.1007/978-3-319-17993-3_4 4. Pre-operative Pulmonary System Evaluation Mesut Subak1 and Fatma Topbas Subak2 (1) Pulmonology Department, Buca Seyfi Demirsoy State Hospital, Izmir, Turkey (2)…
ASA physical status 1 Normal healthy patient No organic, physiologic, or psychiatric disturbance; excludes the very young and very old; healthy with good exercise tolerance ASA physical status 2 Patients…
© Springer International Publishing Switzerland 2015Omer Engin (ed.)Colon Polyps and the Prevention of Colorectal Cancer10.1007/978-3-319-17993-3_7 7. Lower Gastrointestinal Tract Endoscopy in Pregnant Women Ulas Urganci1 (1) Surgery Department, Bozyaka Training and Research Hospital, Izmir, Turkey…
1. Neoplastic polyps Benign (adenoma) Tubular adenoma Tubulovillous adenoma Villous adenoma Malignant (carcinoma) Noninvasive carcinoma Carcinoma in situ Intramucosal carcinoma Invasive carcinoma (through muscularis mucosa) 2. Nonneoplastic polyps Hyperplastic polyp…
Location No. Fistula 4 Enteroenteric 3 Enterocutaneous 1 Intestinal tract 28 Ileum 2 Cecum 2 Descending colon 1 Sigmoid colon 1 Rectum 6 Anal canal 8 Anal fistula 8 7.3…
Fig. 6.1 Surgical options for ulcerative colitis patients with dysplasia found on colonoscopy. IPAA ileal pouch-anal anastomosis, IRA ileorectal anastomosis, TAC total abdominal colectomy, TPC total proctocolectomy 6.3.1 Abdominoperineal Total…
Fig. 3.1 The 5-year overall survival rate in patients with ulcerative colitis–colorectal cancer (UC-CRC). The 5-year overall survival rate was 89 % (Citation from Ref. [15]) Fig. 3.2 The 5-year survival…
Extensive colitis Primary sclerosing cholangitis Severe long-standing inflammation Inflammatory polyps Colonic stricture Family history of colorectal cancer, especially aged <50 Personal history of dysplasia Determination of anatomic extent in assessing…
Fig. 5.1 Molecular pathogenesis of colorectal dysplasia and cancer in inflammatory bowel disease. Summary of the molecular signals, mediators, gene targets, and mechanisms implicated in the progression from mucosal inflammation…
78. Connell WR et al (1994) Lower gastrointestinal malignancy in Crohn’s disease. Gut 35(3):347–352PubMedCentralPubMed 79. Higashi D et al (2007) Study of colorectal cancer with Crohn’s disease. Anticancer Res 27(6A):3771–3774PubMed…
